NRx Pharmaceuticals, Inc. (NRXP)


-0.02 (-1.60%)
Symbol NRXP
Price $1.23
Beta 0.989
Volume Avg. 0.38M
Market Cap 83.260M
Shares () -
52 Week Range 0.49-3.54
1y Target Est -
DCF Unlevered NRXP DCF ->
DCF Levered NRXP LDCF ->
ROE 86276.76% Strong Buy
ROA 82221.68% Strong Buy
Operating Margin -
Debt / Equity 47.92% Neutral
P/E -
P/B 4.87 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest NRXP news

Mr. Richard S. Ackerman J.D.
NASDAQ Global Market

NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.